Vireo's latest marketing efforts emphasize its commitment to educating consumers who are seeking an alternative to Ibuprofen and NSAIDs
MADISON, Tenn., Feb. 12, 2014 /PRNewswire/ — Vireo Systems has recently completed a major packaging and design initiative for its flagship product, AminoActiv ® (http://aminoactiv.com) the #1 alternative to Ibuprofen and NSAIDs. New product labeling and packaging formats are intended to raise AminoActiv's visibility to consumers searching for safe, non-toxic and scientifically proven pain reliever. Central to the new labeling and packaging is the communication of more buyer information that helps consumers and retailers realize the benefits of avoiding NSAIDs (non-steroidal anti-inflammatory drugs).
(Photo: http://photos.prnewswire.com/prnh/20140212/PH63303-a)
(Photo: http://photos.prnewswire.com/prnh/20140212/PH63303-b)
Don Raymond, product manager with the manufacturer, Vireo Systems, Inc., explained, "As AminoActiv expands its presence with retailers in 2014, the new packaging prepares us for reaching consumers who are shopping for alternatives to ibuprofen and other NSAIDs. Our leadership position in this market warranted stronger visual communications about how AminoActiv not only provides effective pain relief, but delivers relief from inflammation without any known side effects."
Raymond added, "Some of our consumers with chronic pain conditions asked for a larger capsule bottle. Responding to their needs, we are introducing a new 180-count capsule bottle, which triples the quantity and lowers costs for these types of AminoActiv consumers compared to the original 60 count bottle product."
The topical cream has undergone a makeover with a convenient topical cream tube design replacing the cream jar. Users will appreciate the increased portability of a tube, which contains the same 2.75 ounces of non-staining, pain and inflammation relief as before.
The 60-count capsule bottle and topical cream tube now come in container boxes, allowing for more product information to be communicated at the point of sale. Vireo reduced paper consumption by printing dosage recommendations and suggested applications on the inside of the box.
CEO Mark Faulkner spoke about Vireo Systems' long-term goals: "Visual communication is an important aspect of growing the AminoActiv brand. Consumers have already expressed appreciation of the effort we've put into meeting their needs and continuing to deliver safe, non-toxic pain relief and healing solutions."
To learn more about the side effects of Ibuprofen and NSAIDs, please visit http://aminoactiv.com/nsaid-warning-information/
New products and prices are viewable now on the AminoActiv® website (http://aminoactiv.com/).
About Vireo Systems, Inc.
Taking inspiration for its name from one of the Latin words for "health," Vireo Systems, Inc. is the manufacturer of a number of nutraceuticals and health support products including AminoActiv®, the #1 alternative to ibuprofen and NSAIDs. Vireo was founded in 2002 as part of a project with several university-based researchers, and today, the company's products deliver safe, effective relief for inflammation, pain and other ailments. Vireo meets industry-standard good manufacturing practices as expected by the FDA, and AminoActiv safety and toxicity data have been reviewed and accepted by the FDA.
Vireo is headquartered just outside Nashville, Tenn., with a secondary facility in Plattsmouth, Neb., where it manufactures its pain relief capsules and cream. Vireo is a certified SQF facility, the highest designation for quality products and processes.
Contact:
Mark Faulkner
President, Vireo Systems, Inc.
855-442-6466
Email